US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US6334997B1
(en)
*
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
AU745236B2
(en)
*
|
1997-02-14 |
2002-03-14 |
George Washington University, The |
An assay for the measurement of DNA synthesis rates
|
US6312450B1
(en)
|
1997-05-20 |
2001-11-06 |
Natural Vision Center, Inc. |
System and method for improving the appearance of skin
|
US20030220234A1
(en)
*
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
ATE314388T1
(de)
|
1997-10-08 |
2006-01-15 |
Isotechnika Inc |
Deuterierte und undeuterierte cyclosporin-analoga und ihre verwendung als immunmodulierende agentien
|
EP1645565B1
(en)
*
|
1997-10-08 |
2009-02-18 |
Isotechnika Inc. |
Deuterated cyclosporine analogs and their use as immunomodulating agents
|
US6333342B1
(en)
*
|
1998-11-04 |
2001-12-25 |
Isotechnika, Inc |
Methods of pharmacological treatment using S(−) amlodipine
|
US6376531B1
(en)
|
1998-11-13 |
2002-04-23 |
Rupert Charles Bell |
Method of treatment using deuterium compounds
|
US7323341B1
(en)
|
1999-07-09 |
2008-01-29 |
Jasper John P |
Stable isotopic identification and method for identifying products by isotopic concentration
|
US6254594B1
(en)
|
1999-07-30 |
2001-07-03 |
Quadrivium, Llc |
Disposable light source for photothermal treatment of human tissue
|
RU2181297C2
(ru)
|
2000-06-20 |
2002-04-20 |
Эпштейн Олег Ильич |
Способ лечения патологического синдрома и лекарственное средство
|
US6579630B2
(en)
|
2000-12-07 |
2003-06-17 |
Canon Kabushiki Kaisha |
Deuterated semiconducting organic compounds used for opto-electronic devices
|
US6872408B2
(en)
*
|
2001-09-07 |
2005-03-29 |
Rupert C. Bell |
Method of treating bipolar disorders using deuterium-substituted carbonate
|
CA2463469A1
(en)
|
2001-10-16 |
2003-04-24 |
Memory Pharmaceuticals Corporation |
4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
|
SI1436321T1
(sl)
|
2001-10-19 |
2006-12-31 |
Isotechnika Inc |
Sinteza analogov ciklosporina
|
RU2201255C1
(ru)
*
|
2001-12-26 |
2003-03-27 |
Эпштейн Олег Ильич |
Лекарственное средство и способ регуляции сосудистого тонуса
|
DE10205432A1
(de)
*
|
2002-02-07 |
2003-08-21 |
Bdd Group Holding Ag Zug |
Deuterierte biphenylsubstituierte Spirocyclopentanimidazoline sowie diese Verbindungen enthaltende Arzneimittel
|
UA76639C2
(uk)
*
|
2002-08-02 |
2006-08-15 |
Олєг Ільіч Епштєйн |
Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
|
UA76640C2
(uk)
*
|
2002-08-02 |
2006-08-15 |
Олєг Ільіч Епштєйн |
Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
|
CA2495248A1
(en)
|
2002-08-30 |
2004-03-11 |
Memory Pharmaceuticals Corporation |
Anabaseine derivatives useful in the treatment of neurodegenerative diseases
|
CA2499128C
(en)
|
2002-09-25 |
2012-07-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
|
WO2004046113A2
(en)
|
2002-11-19 |
2004-06-03 |
Memory Pharmaceuticals Corporation |
Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
|
EP1603512A2
(en)
*
|
2003-03-17 |
2005-12-14 |
Albany Molecular Research, Inc. |
Novel cyclosporins
|
AU2004232958A1
(en)
*
|
2003-04-16 |
2004-11-04 |
F.-Hoffmann La-Roche Inc. |
4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
|
KR20060005375A
(ko)
*
|
2003-04-18 |
2006-01-17 |
메모리 파마슈티칼스 코포레이션 |
포스포디에스테라제 4 억제제로서의 피라졸 유도체
|
US20050043288A1
(en)
*
|
2003-08-21 |
2005-02-24 |
Thomas Tobin |
Composition and method for marking procaine penicillin
|
RU2253478C1
(ru)
*
|
2003-10-01 |
2005-06-10 |
Эпштейн Олег Ильич |
Средство для потенцирования лечебных эффектов - усиления действия лекарственного вещества
|
CA2546366A1
(en)
|
2003-11-21 |
2005-06-09 |
Memory Pharmaceuticals Corporation |
Using of (+)-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dymethyl-pyridine-3,5-dicarboxylate in the treatment of memory disorders
|
RU2417225C2
(ru)
|
2004-03-25 |
2011-04-27 |
Мемори Фармасьютиклз Корпорейшн |
Индазолы, бензотиазолы, бензоизотиазолы, бензизоксазолы и их получение и применение
|
US7754897B2
(en)
*
|
2005-06-15 |
2010-07-13 |
Cardiome Pharma Corp. |
Synthetic processes for the preparation of aminocyclohexyl ether compounds
|
US7705036B2
(en)
*
|
2004-04-01 |
2010-04-27 |
Cardiome Pharma Corp. |
Deuterated aminocyclohexyl ether compounds and processes for preparing same
|
MXPA06011420A
(es)
*
|
2004-04-01 |
2007-04-20 |
Cardiome Pharma Corp |
Compuestos pegilados de modulacion de canal de iones.
|
JP2008514701A
(ja)
*
|
2004-09-29 |
2008-05-08 |
エーエムアール テクノロジー インコーポレイテッド |
シクロスポリンアルキン類似体およびそれらの薬学的使用
|
US7511013B2
(en)
*
|
2004-09-29 |
2009-03-31 |
Amr Technology, Inc. |
Cyclosporin analogues and their pharmaceutical uses
|
JP2008515886A
(ja)
*
|
2004-10-06 |
2008-05-15 |
エーエムアール テクノロジー インコーポレイテッド |
シクロスポリンアルキンおよびそれらの医用薬剤としての有用性
|
JP2008516964A
(ja)
|
2004-10-15 |
2008-05-22 |
メモリー ファーマシューティカルス コーポレーション |
ホスホジエステラーゼ4阻害剤としてのピラゾール誘導体
|
EP1802615A1
(en)
*
|
2004-10-20 |
2007-07-04 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors
|
JP5159314B2
(ja)
|
2004-11-18 |
2013-03-06 |
カーディオム ファーマ コーポレイション |
アミノシクロヘキシルエーテル化合物の合成方法
|
KR101380190B1
(ko)
*
|
2005-07-29 |
2014-04-11 |
콘서트 파마슈티컬즈, 인크. |
벤조 〔d〕〔1,3〕―디옥솔 유도체
|
US7863274B2
(en)
|
2005-07-29 |
2011-01-04 |
Concert Pharmaceuticals Inc. |
Deuterium enriched analogues of tadalafil as PDE5 inhibitors
|
CA2631581C
(en)
|
2005-12-01 |
2011-05-03 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
|
RU2309732C1
(ru)
*
|
2006-03-13 |
2007-11-10 |
Олег Ильич Эпштейн |
Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
|
US7696165B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
US7696166B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
|
BRPI0711228A2
(pt)
*
|
2006-05-26 |
2012-06-19 |
Auspex Pharmaceuticals Inc |
"composto, método de tratar um mamìfero que sofre de um doença ou de uma condição envolvendo as enzimas ciclooxiganase, composição farmacêutica, processo para e deuteração de um composto pelatroca de pelomenos um átomo de hidrogênio do dito composto com um átomo do deutério e processo para preparar m composto"
|
WO2007142945A2
(en)
|
2006-05-30 |
2007-12-13 |
Jasper John P |
Tracing processes between precursors and products by utilizing isotopic relationships
|
US20070281894A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
CN101516879A
(zh)
|
2006-06-05 |
2009-08-26 |
奥斯拜客斯制药有限公司 |
具有催眠作用的取代的咪唑并吡啶化合物的制备及用途
|
US8299248B2
(en)
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
WO2008021891A2
(en)
*
|
2006-08-08 |
2008-02-21 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects
|
WO2008022285A1
(en)
|
2006-08-16 |
2008-02-21 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of opioid analgesics
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
WO2008061108A2
(en)
*
|
2006-11-15 |
2008-05-22 |
Forest Laboratories Holdings Limited |
Phthalazine derivatives
|
WO2008063600A2
(en)
*
|
2006-11-17 |
2008-05-29 |
Concert Pharmaceuticals Inc. |
Triazolyl tropane derivatives
|
US20080146573A1
(en)
*
|
2006-12-04 |
2008-06-19 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted oxzolidinones
|
WO2008076949A2
(en)
|
2006-12-15 |
2008-06-26 |
Concert Pharmaceuticals Inc. |
Quinazoline derivatives and methods of treatment
|
WO2008088727A2
(en)
*
|
2007-01-12 |
2008-07-24 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
US8080549B2
(en)
|
2007-01-12 |
2011-12-20 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
WO2008106125A2
(en)
|
2007-02-26 |
2008-09-04 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists
|
JP2010520291A
(ja)
|
2007-03-07 |
2010-06-10 |
コンサート ファーマシューティカルズ インコーポレイテッド |
抗狭心症化合物としての重水素化ピペラジン誘導体
|
WO2008140859A1
(en)
|
2007-03-15 |
2008-11-20 |
Auspex Pharmaceuticals, Inc. |
Deuterated venlafaxines and 0-desmetylvenlafaxines with serotoninergic and / or norepinephrinergic activity
|
ES2559838T3
(es)
|
2007-03-16 |
2016-02-16 |
Concert Pharmaceuticals, Inc. |
Inhibidores de proteína de transferencia de ésteres de colesterol
|
CN101730694A
(zh)
|
2007-04-10 |
2010-06-09 |
奥斯拜客斯制药有限公司 |
用于治疗高血压的取代的氘富集的噻吩
|
US8349817B2
(en)
|
2007-04-25 |
2013-01-08 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
ES2401914T3
(es)
|
2007-04-25 |
2013-04-25 |
Concert Pharmaceuticals Inc. |
Análogos de Cilostazol
|
CN101765582A
(zh)
|
2007-04-26 |
2010-06-30 |
奥斯拜客斯制药有限公司 |
氘标记的氯胺酮
|
HUE063526T2
(hu)
|
2007-05-01 |
2024-01-28 |
Concert Pharmaceuticals Ind Inc |
Morfinvegyületek
|
PT2345653E
(pt)
|
2007-05-01 |
2013-04-01 |
Concert Pharmaceuticals Inc |
Compostos de morfinano
|
US20080280970A1
(en)
|
2007-05-08 |
2008-11-13 |
Czarnik Anthony W |
Deuterium-enriched atorvastatin
|
WO2008141021A1
(en)
|
2007-05-08 |
2008-11-20 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of tetrahydrotriazolopyrazine compounds and their use as dpp-iv inhibitors
|
HUP0700353A2
(en)
*
|
2007-05-18 |
2008-12-29 |
Richter Gedeon Nyrt |
Metabolites of (thio)carbamoyl-cyclohexane derivatives
|
US7531685B2
(en)
*
|
2007-06-01 |
2009-05-12 |
Protia, Llc |
Deuterium-enriched oxybutynin
|
WO2008151179A2
(en)
|
2007-06-04 |
2008-12-11 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines
|
ES2356334T3
(es)
|
2007-06-12 |
2011-04-07 |
Concert Pharmaceuticals, Inc. |
Derivados de azapéptidos como inhibidores de la proteasa vih.
|
US20080312318A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Protia, Llc |
Deuterium-enriched escitalopram
|
US20080318964A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Protia, Llc |
Deuterium-enriched eszopiclone
|
CA2691379C
(en)
|
2007-06-20 |
2015-06-09 |
Auspex Pharmaceuticals, Inc. |
Substituted n-aryl pyridinones
|
US7915309B2
(en)
|
2007-06-20 |
2011-03-29 |
Protia, Llc |
Deuterium-enriched oseltamivir
|
WO2009009531A2
(en)
|
2007-07-09 |
2009-01-15 |
Concert Pharmaceuticals Inc. |
Pyrimidinecarboxamide derivatives for the treatment of hiv infections
|
WO2009018280A2
(en)
*
|
2007-07-30 |
2009-02-05 |
Auspex Pharamaceuticals, Inc. |
Substituted indoles
|
EP2190841B1
(en)
|
2007-08-14 |
2013-05-15 |
Concert Pharmaceuticals Inc. |
Substituted oxazolidinone derivatives
|
US20090062182A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched dalbavancin
|
US7767860B2
(en)
|
2007-09-06 |
2010-08-03 |
Auspex Pharmaceuticals, Inc |
Substituted amino alcohols
|
US20090069395A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched famotidine
|
US8304435B2
(en)
|
2007-09-12 |
2012-11-06 |
Deuteria Pharmaceuticals Inc. |
Deuterium-enriched donepezil
|
US8288414B2
(en)
|
2007-09-12 |
2012-10-16 |
Deuteria Pharmaceuticals, Inc. |
Deuterium-enriched lenalidomide
|
WO2009035662A1
(en)
|
2007-09-12 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Deuterated 4 -oxoquinoline derivatives for the treatment of hiv infection
|
US8669268B2
(en)
|
2007-09-12 |
2014-03-11 |
Deuterx, Llc |
Deuterium-enriched prasugrel
|
US7919516B2
(en)
|
2007-09-13 |
2011-04-05 |
Protia, Llc |
Deuterium-enriched ondansetron
|
US20090076161A1
(en)
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched bupropion
|
CA2698808A1
(en)
|
2007-09-13 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
|
US8026249B2
(en)
|
2007-09-14 |
2011-09-27 |
Deutena Pharmaceuticals, Inc. |
Deuterium-enriched topotecan
|
US7776866B2
(en)
|
2007-09-15 |
2010-08-17 |
Protia, Llc |
Deuterium-enriched risperidone
|
US7842675B2
(en)
|
2007-09-15 |
2010-11-30 |
Protia, Llc |
Deuterium-enriched capecitabine
|
US7956080B2
(en)
|
2007-09-25 |
2011-06-07 |
Protra, LLC |
Deuterium-enriched SDX-101
|
US8722710B2
(en)
|
2007-09-26 |
2014-05-13 |
Deuterx, Llc |
Deuterium-enriched pioglitazone
|
US20090082259A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched octreotide
|
US8410124B2
(en)
*
|
2007-10-18 |
2013-04-02 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
US20090105338A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Protia, Llc |
Deuterium-enriched gabexate mesylate
|
US8592487B2
(en)
|
2007-10-26 |
2013-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
US7875610B2
(en)
*
|
2007-12-03 |
2011-01-25 |
Richter Gedeon Nyrt. |
Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
|
US8338425B2
(en)
|
2007-12-10 |
2012-12-25 |
Concert Pharmaceuticals, Inc. |
Heterocyclic kinase inhibitors
|
WO2009079637A1
(en)
*
|
2007-12-18 |
2009-06-25 |
Concert Pharmaceuticals, Inc. |
Tetrahydroisoquinoline derivatives
|
US8609673B2
(en)
|
2008-01-22 |
2013-12-17 |
Concert Pharmaceuticals, Inc. |
Vandetanib derivatives
|
WO2009094216A1
(en)
|
2008-01-22 |
2009-07-30 |
Concert Pharmaceuticals Inc. |
Derivatives of gefitinib
|
JP5496915B2
(ja)
|
2008-02-13 |
2014-05-21 |
シージーアイ ファーマシューティカルズ,インコーポレーテッド |
6−アリール−イミダゾ[1,2−a]ピラジン誘導体、その製造方法、及びその使用方法
|
EP2251011B1
(en)
*
|
2008-02-21 |
2012-04-04 |
Richter Gedeon Nyrt. |
Solid preparation for oral administration
|
US10029956B2
(en)
*
|
2008-03-14 |
2018-07-24 |
Retrotope, Inc. |
Therapies for cancer using isotopically substituted lysine
|
JP2011518774A
(ja)
*
|
2008-03-20 |
2011-06-30 |
フォレスト・ラボラトリーズ・ホールディングス・リミテッド |
ステアロイル−CoAデサチュラーゼの阻害剤としての新規ピペリジン誘導体
|
WO2009117659A1
(en)
*
|
2008-03-20 |
2009-09-24 |
Forest Laboratories Holdings Limited |
Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase
|
WO2009128947A1
(en)
|
2008-04-17 |
2009-10-22 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
WO2009148600A2
(en)
*
|
2008-06-06 |
2009-12-10 |
Concert Pharmaceuticals, Inc. |
Deuterated lysine-based compounds
|
WO2009154754A2
(en)
|
2008-06-17 |
2009-12-23 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated morpholine derivatives
|
US20100016297A1
(en)
*
|
2008-06-24 |
2010-01-21 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
WO2009158005A1
(en)
*
|
2008-06-27 |
2009-12-30 |
Concert Pharmaceuticals, Inc. |
Benzazepinone compounds
|
WO2010005520A2
(en)
*
|
2008-06-30 |
2010-01-14 |
Concert Pharmaceuticals, Inc. |
2-alkyl-3-acylpyrazolo[1,5-a]pyridine derivatives
|
WO2010002451A1
(en)
*
|
2008-07-01 |
2010-01-07 |
Concert Pharmaceuticals, Inc. |
Naphthyridin derivatives
|
US20100022581A1
(en)
*
|
2008-07-02 |
2010-01-28 |
Memory Pharmaceuticals Corporation |
Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity
|
PL2317852T3
(pl)
|
2008-07-16 |
2015-05-29 |
Richter Gedeon Nyrt |
Preparaty farmaceutyczne zawierające ligandy receptora dopaminy
|
US20100093758A1
(en)
*
|
2008-07-23 |
2010-04-15 |
Auspex Pharmaceuticals, Inc. |
Pyridine sulfonamide modulators of endothelin-a receptor
|
US20100029629A1
(en)
*
|
2008-07-25 |
2010-02-04 |
Memory Pharmaceuticals Corporation |
Acyclic compounds having 5-ht6 receptor affinity
|
KR101671537B1
(ko)
|
2008-08-11 |
2016-11-01 |
넥타르 테라퓨틱스 |
다분지형 중합체 알카노에이트 컨쥬게이트
|
US20100221221A1
(en)
*
|
2008-08-12 |
2010-09-02 |
Concert Pharmaceuticals Inc. |
N-phenyl-2-pyrimidineamine derivatives
|
WO2010019560A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of donepezil
|
US20100056531A1
(en)
*
|
2008-08-22 |
2010-03-04 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
US20100074973A1
(en)
*
|
2008-08-27 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Thioxanthene modulators of dopamine d2 receptors
|
JP5183808B2
(ja)
|
2008-08-29 |
2013-04-17 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換トリアゾロ−ピリダジン誘導体
|
WO2010028015A2
(en)
*
|
2008-09-03 |
2010-03-11 |
Auspex Pharmaceuticals, Inc |
2-oxo-1,2-dihydro-quinoline modulators of immune function
|
WO2010033511A1
(en)
|
2008-09-16 |
2010-03-25 |
Concert Pharmaceuticals, Inc. |
Deuterated 2-amino-3-hydroxypropanoic acid derivatives
|
AU2015258262B2
(en)
*
|
2008-09-19 |
2016-08-18 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
AU2013204067B2
(en)
*
|
2008-09-19 |
2014-02-27 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
WO2010036773A1
(en)
*
|
2008-09-24 |
2010-04-01 |
Concert Pharmaceuticals, Inc. |
Deuterated l-aryl-2 -aminomethyl cyclopropane carboxyamide derivatives
|
WO2010036796A1
(en)
*
|
2008-09-26 |
2010-04-01 |
Concert Pharmaceuticals, Inc. |
Pyridineamine derivatives
|
US20100113606A1
(en)
*
|
2008-11-05 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
Aminopropanol modulators of beta-1 adrenergic receptor
|
US20100113431A1
(en)
*
|
2008-11-05 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
N-methyl piperazine modulators of h1 receptor
|
WO2010056741A2
(en)
|
2008-11-12 |
2010-05-20 |
Auspex Pharmaceuticals, Inc. |
Phenylacetic acid inhibitors of cyclooxygenase
|
US9045453B2
(en)
|
2008-11-14 |
2015-06-02 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
US20100137215A1
(en)
*
|
2008-11-25 |
2010-06-03 |
Concert Pharmaceuticals Inc. |
Novel tetrahydro-1h-pyrido[4,3-b]indoles
|
HUE030427T2
(en)
|
2008-12-08 |
2017-05-29 |
Gilead Connecticut Inc |
Imidazopyrazine Syk inhibitors
|
US8450321B2
(en)
|
2008-12-08 |
2013-05-28 |
Gilead Connecticut, Inc. |
6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
|
JP5696052B2
(ja)
|
2008-12-08 |
2015-04-08 |
ギリアード コネチカット, インコーポレイテッド |
イミダゾピラジンsyk阻害剤
|
HU230067B1
(hu)
|
2008-12-17 |
2015-06-29 |
Richter Gedeon Nyrt |
Új piperazin só és eljárás előállítására
|
HUP0800766A2
(en)
|
2008-12-18 |
2010-11-29 |
Richter Gedeon Vegyeszet |
Process for the preparation of piperazine derivatives
|
HUP0800765A2
(en)
|
2008-12-18 |
2010-11-29 |
Richter Gedeon Nyrt |
A new process for the preparation of piperazine derivatives and their hydrochloric salts
|
US8263601B2
(en)
|
2009-02-27 |
2012-09-11 |
Concert Pharmaceuticals, Inc. |
Deuterium substituted xanthine derivatives
|
US8563554B2
(en)
|
2009-03-17 |
2013-10-22 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
WO2010118291A2
(en)
|
2009-04-10 |
2010-10-14 |
Auspex Pharmaceuticals, Inc. |
Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
|
AU2010239396B2
(en)
|
2009-04-20 |
2016-06-23 |
Auspex Pharmaceuticals, Llc |
Piperidine inhibitors of Janus Kinase 3
|
US8461197B2
(en)
|
2009-04-23 |
2013-06-11 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
US20100305173A1
(en)
*
|
2009-04-30 |
2010-12-02 |
Concert Pharmaceuticals, Inc. |
Hydroxyethylamino sulfonamide derivatives
|
US20120058085A1
(en)
*
|
2009-05-15 |
2012-03-08 |
Persichetti Rose A |
Deuterium Modified Benzimidazoles
|
WO2010135579A1
(en)
|
2009-05-22 |
2010-11-25 |
Concert Pharmaceuticals, Inc. |
Fluorinated diaryl urea derivatives
|
US20120244122A1
(en)
*
|
2009-05-28 |
2012-09-27 |
Masse Craig E |
Peptides for the Treatment of HCV Infections
|
US20110053968A1
(en)
|
2009-06-09 |
2011-03-03 |
Auspex Pharmaceuticals, Inc. |
Aminopyrimidine inhibitors of tyrosine kinase
|
US8586760B2
(en)
|
2009-06-15 |
2013-11-19 |
Auspex Pharmaceuticals, Inc. |
Aminothiazole modulators of beta-3-adrenoreceptor
|
ES2469849T3
(es)
|
2009-06-18 |
2014-06-20 |
Concert Pharmaceuticals Inc. |
Derivados deuterados de isoindolin-1,3-diona como inhibidores de PDE4 y TNF-alfa
|
US8501738B2
(en)
|
2009-06-23 |
2013-08-06 |
Concert Pharmaceuticals, Inc. |
Substituted triazolo-pyridazine derivatives
|
JP2012533567A
(ja)
*
|
2009-07-17 |
2012-12-27 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
重水素化2,4−ピリミジンジアミン化合物およびそのプロドラッグならびにそれらの使用
|
US8637524B2
(en)
|
2009-07-28 |
2014-01-28 |
Auspex Pharmaceuticals, Inc |
Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2
|
US9512104B2
(en)
|
2009-07-28 |
2016-12-06 |
Auspex Pharmaceuticals, Inc. |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
US8575348B2
(en)
|
2009-07-28 |
2013-11-05 |
Auspex Pharmaceuticals, Inc |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
US20110105603A1
(en)
*
|
2010-08-06 |
2011-05-05 |
American Life Science Pharmaceuticals, Inc. |
Compositions and methods for treating beta-amyloid related diseases
|
EP3296295A1
(en)
*
|
2009-08-07 |
2018-03-21 |
American Life Science Pharmaceuticals, Inc. |
Compositions and methods for treating beta-amyloid related diseases
|
US8530479B2
(en)
*
|
2009-08-10 |
2013-09-10 |
Daljit Singh Dhanoa |
Deuterium-enriched alkyl sulfonamides
|
US8557815B2
(en)
|
2009-08-14 |
2013-10-15 |
Concert Pharmaceuticals, Inc. |
Substituted triazolophthalazine derivatives
|
US8658236B2
(en)
|
2009-08-21 |
2014-02-25 |
Deuteria Beverages, Llc |
Alcoholic compositions having a lowered risk of acetaldehydemia
|
EP2473052A4
(en)
|
2009-09-02 |
2013-03-20 |
Concert Pharmaceuticals Inc |
SUBSTITUTED XANTHINE DERIVATIVES
|
US9260432B2
(en)
|
2009-09-02 |
2016-02-16 |
Concert Pharmaceuticals, Inc. |
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
|
CN101666757B
(zh)
*
|
2009-09-25 |
2011-03-16 |
广东省药品检验所 |
中草药降压产品中掺杂二氢吡啶类降压化合物的快筛方法
|
KR20120110090A
(ko)
*
|
2009-09-28 |
2012-10-09 |
에프. 호프만-라 로슈 리미티드 |
C형 간염 바이러스 복제의 신규한 마크로시클릭 저해제
|
US8278460B2
(en)
|
2009-10-15 |
2012-10-02 |
Concert Pharmaceuticals, Inc. |
Substituted benzimidazoles
|
WO2011056511A2
(en)
|
2009-10-26 |
2011-05-12 |
Auspex Pharmaceuticals, Inc. |
4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
|
RU2012121847A
(ru)
|
2009-10-28 |
2013-12-10 |
Анадис Фармасьютикалз, Инк. |
Дейтерированные соединения 5, 6-дигидро-1н-пиридин-2-она
|
JP2013510098A
(ja)
*
|
2009-11-04 |
2013-03-21 |
シセン ペイリコク バイオテクノロジー リミテッド ライアビリティ カンパニー |
特定の結晶性水和物、その医薬組成物、ならびにその調製方法および使用方法
|
WO2011056764A1
(en)
*
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
US8471034B2
(en)
|
2009-11-18 |
2013-06-25 |
Concert Pharmaceuticals, Inc. |
Niacin prodrugs and deuterated versions thereof
|
US20110152303A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Glaxosmithkline Llc |
Chemical Compounds
|
EP2523966B1
(en)
|
2010-01-15 |
2017-10-04 |
Suzhou Neupharma Co., Ltd |
Certain chemical entities, compositions, and methods
|
EP2536696A1
(en)
*
|
2010-02-18 |
2012-12-26 |
Concert Pharmaceuticals Inc. |
Pyrimidine derivatives
|
US8513434B2
(en)
|
2010-03-02 |
2013-08-20 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
NZ602362A
(en)
|
2010-03-11 |
2014-11-28 |
Gilead Connecticut Inc |
Imidazopyridines syk inhibitors
|
WO2011116066A1
(en)
|
2010-03-17 |
2011-09-22 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
US9133123B2
(en)
|
2010-04-23 |
2015-09-15 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
WO2012006070A1
(en)
*
|
2010-06-28 |
2012-01-12 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of flavivirus infections
|
MY157564A
(en)
|
2010-07-15 |
2016-06-30 |
Epshtein Oleg Lliich |
Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
|
DE112011102362T5
(de)
|
2010-07-15 |
2013-04-25 |
Oleg Iliich Epshtein |
Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Erkrankungen oder Zuständen, die mit neurodegenerativen Erkrankungen in Verbindung stehen
|
US9308275B2
(en)
|
2010-07-15 |
2016-04-12 |
Oleg Iliich Epshtein |
Method of increasing the effect of an activated-potentiated form of an antibody
|
US9107922B2
(en)
|
2010-07-16 |
2015-08-18 |
Concert Pharmaceuticals, Inc. |
Pyrimidinecarboxamide derivatives
|
EA029199B1
(ru)
|
2010-07-21 |
2018-02-28 |
Олег Ильич Эпштейн |
Комбинированная фармацевтическая композиция для лечения синдрома дефицита внимания и гиперактивности и способы лечения синдрома дефицита внимания и гиперактивности
|
AU2011292959B2
(en)
|
2010-08-23 |
2016-06-09 |
Suzhou Neupharma Co., Ltd. |
Certain chemical entities, compositions, and methods
|
CN102656179B
(zh)
|
2010-08-28 |
2015-07-29 |
苏州润新生物科技有限公司 |
蟾蜍灵衍生物、其药物组合物及用途
|
US9085788B2
(en)
|
2010-09-01 |
2015-07-21 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
US9074233B2
(en)
|
2010-09-01 |
2015-07-07 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
AU2011313853A1
(en)
|
2010-10-11 |
2013-05-02 |
Auckland Uniservices Limited |
Substituted benzamides and their uses
|
US10894087B2
(en)
|
2010-12-22 |
2021-01-19 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
US20130331443A1
(en)
|
2010-12-22 |
2013-12-12 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
CN103619865B
(zh)
|
2011-02-02 |
2016-10-12 |
苏州润新生物科技有限公司 |
某些化学个体、组合物及方法
|
US8759394B2
(en)
|
2011-02-14 |
2014-06-24 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
US9145390B2
(en)
|
2011-03-03 |
2015-09-29 |
Concert Pharmaceuticals, Inc. |
Derivatives of pyrazole-substituted amino-heteroaryl compounds
|
WO2012122028A2
(en)
|
2011-03-04 |
2012-09-13 |
Concert Pharmaceuticals Inc. |
Pyrazinoisoquinoline compounds
|
KR20140011355A
(ko)
|
2011-03-08 |
2014-01-28 |
오스펙스 파마슈티칼스, 인코포레이티드 |
치환된 n아릴 피리디논
|
AU2012236655B2
(en)
|
2011-03-28 |
2016-09-22 |
Deuterx, Llc, |
2',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compounds
|
ES2579319T3
(es)
*
|
2011-05-04 |
2016-08-09 |
Balance Therapeutics, Inc. |
Derivados de pentilenotetrazol
|
US8691808B2
(en)
|
2011-05-20 |
2014-04-08 |
Influmedix, Inc. |
Antiviral compounds and their methods of use
|
JP5925301B2
(ja)
*
|
2011-05-23 |
2016-05-25 |
サノフイ |
N−アルキル基を含有するジュウテリウム化化合物の製造方法
|
US8778223B2
(en)
|
2011-05-24 |
2014-07-15 |
Lc Vision, Llc |
Liquid crystals having cyclohexyl core structures and fluorinated tails
|
CN105294690B
(zh)
|
2011-06-17 |
2018-07-10 |
辉瑞抗感染公司 |
制备包括反-7-氧代-6-(磺基氧基)-1,6-二氮杂二环[3,2,1]辛烷-2-甲酰胺的杂环化合物及其盐的方法
|
JP5668177B2
(ja)
|
2011-06-20 |
2015-02-12 |
ハー・ルンドベック・アクチエゼルスカベット |
統合失調症の治療のための重水素化1−ピペラジノ−3−フェニルインダン
|
CA2846574C
(en)
|
2011-08-26 |
2020-07-07 |
Neupharma, Inc. |
Quinoxaline sulfonamide derivates for use as kinase inhibitors
|
CN104080335B
(zh)
|
2011-09-01 |
2017-06-09 |
钱向平 |
某些化学实体、组合物及方法
|
CA2848506C
(en)
|
2011-09-14 |
2020-07-21 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
WO2013043935A1
(en)
|
2011-09-21 |
2013-03-28 |
Neupharma, Inc. |
Certain chemical entites, compositions, and methods
|
WO2013049701A1
(en)
|
2011-09-30 |
2013-04-04 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
CN104053771B
(zh)
|
2011-11-18 |
2016-11-09 |
科德克希思公司 |
用于制备羟基取代的氨基甲酸酯的生物催化剂
|
CN104736158A
(zh)
|
2012-01-23 |
2015-06-24 |
萨奇治疗股份有限公司 |
神经活性类固醇制剂和治疗中枢神经系统障碍的方法
|
WO2013112950A2
(en)
|
2012-01-25 |
2013-08-01 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
WO2013132263A1
(en)
*
|
2012-03-09 |
2013-09-12 |
Axelar Ab |
Picropodophyllin derivatives for use in therapy
|
JP6275690B2
(ja)
|
2012-04-05 |
2018-02-07 |
シーエイチディーアイ ファウンデーション,インコーポレーテッド |
キヌレニン−3−モノオキシゲナーゼインヒビターおよびその医薬組成物ならびにこれらの使用方法
|
RU2014141510A
(ru)
|
2012-04-12 |
2016-06-10 |
Дзе Борд Оф Трастиз Оф Дзе Лелэнд Стэнфорд Джуниор Юниверсити |
Замещенные бензамиды и их применения, перекрестная ссылка на связанные заявки
|
US9328113B2
(en)
|
2012-04-13 |
2016-05-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
US9249093B2
(en)
|
2012-04-20 |
2016-02-02 |
Concert Pharmaceuticals, Inc. |
Deuterated rigosertib
|
CN109354598A
(zh)
|
2012-04-29 |
2019-02-19 |
润新生物公司 |
化学个体、药物组合物及癌症治疗方法
|
US20150197525A1
(en)
|
2012-06-15 |
2015-07-16 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of ruxolitinib
|
CN102757417B
(zh)
|
2012-06-18 |
2014-09-24 |
中国科学院广州生物医药与健康研究院 |
氘代苯并吡喃类化合物及其应用
|
US9181190B2
(en)
|
2012-07-04 |
2015-11-10 |
Concert Pharmaceuticals, Inc. |
Deuterated vercirnon
|
US10017445B2
(en)
|
2012-07-12 |
2018-07-10 |
Concert Pharmaceuticals, Inc. |
Deuterated idebenone
|
KR20150038486A
(ko)
|
2012-07-30 |
2015-04-08 |
콘서트 파마슈티컬즈, 인크. |
중수소화된 아이브루티닙
|
GB201214169D0
(en)
|
2012-08-08 |
2012-09-19 |
Biostatus Ltd |
New compounds and uses thereof
|
EP3492472A1
(en)
|
2012-08-17 |
2019-06-05 |
Concert Pharmaceuticals Inc. |
Deuterated baricitinib with improved metabolic stability as jak1 and jak2 kinase inhibitor for treating e.g. rheumatoid arthritis
|
RU2667010C2
(ru)
|
2012-08-21 |
2018-09-13 |
Сейдж Терапьютикс, Инк. |
Способы лечения эпилепсии или эпилептического статуса
|
WO2014031732A2
(en)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Methods for inhibiting fascin
|
CA2883641C
(en)
|
2012-09-18 |
2021-09-14 |
Auspex Pharmaceuticals, Inc. |
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
|
US9550780B2
(en)
|
2012-09-18 |
2017-01-24 |
Auspex Pharmaceuticals, Inc. |
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
|
EP2897618B1
(en)
|
2012-09-24 |
2021-11-17 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
JP2015534989A
(ja)
|
2012-10-22 |
2015-12-07 |
コンサート ファーマシューティカルズ インコーポレイテッド |
{s−3−(4−アミノ−1−オキソ−イソインドリン−2−イル)(ピペリジン−3,4,4,5,5−d5)−2,6−ジオン}の固体形態
|
US9725421B2
(en)
|
2012-11-12 |
2017-08-08 |
Neupharma, Inc. |
Substituted quinoxalines as B-raf kinase inhibitors
|
CN109364075B
(zh)
*
|
2012-11-21 |
2021-10-29 |
顶点制药(欧洲)有限公司 |
氘化cftr增效剂
|
WO2014100431A1
(en)
*
|
2012-12-20 |
2014-06-26 |
Concert Pharmaceuticals, Inc. |
Deuterated alk inhibitors
|
AU2014205472B2
(en)
|
2013-01-09 |
2018-05-10 |
Concert Pharmaceuticals Inc. |
Deuterated momelotinib
|
US9540340B2
(en)
|
2013-01-14 |
2017-01-10 |
Deuterx, Llc |
3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
|
GB201302368D0
(en)
*
|
2013-02-11 |
2013-03-27 |
Univ Bath |
Compound
|
CA2941562C
(en)
|
2013-03-14 |
2021-09-21 |
Deuterx, Llc |
Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
|
EP2968334A4
(en)
|
2013-03-14 |
2016-08-03 |
Deuterx Llc |
3- (SUBSTITIERTES-4-OXO-quinazolin-3 (4H) -yl) -3-deutero-PIPERIDINE-2,6-DIONE DERIVATIVES
|
AU2014233179B2
(en)
|
2013-03-15 |
2018-04-26 |
Deuteria Agrochemicals, Llc |
Deuterium-enriched aldehydes
|
WO2014150043A1
(en)
|
2013-03-15 |
2014-09-25 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
US9713330B1
(en)
|
2013-03-15 |
2017-07-25 |
Deuteria Agrochemicals, Llc |
Deuterium-enriched aldehydes
|
AP2016009007A0
(en)
|
2013-07-30 |
2016-01-31 |
Gilead Connecticut Inc |
Formulation of syk inhibitors
|
TW201602108A
(zh)
|
2013-07-30 |
2016-01-16 |
吉李德康乃狄克公司 |
脾酪胺酸激酶(Syk)抑制劑之多晶型
|
PL3035936T3
(pl)
|
2013-08-23 |
2019-08-30 |
Neupharma, Inc. |
Pewne jednostki chemiczne, kompozycje i sposoby
|
US9676790B2
(en)
|
2013-08-30 |
2017-06-13 |
Concert Pharmaceuticals, Inc. |
Substituted thienotriazolodiazapines
|
CN105873589B
(zh)
|
2013-12-03 |
2019-11-01 |
奥斯拜客斯制药有限公司 |
制造苯并喹啉化合物的方法
|
AU2014360452C1
(en)
|
2013-12-03 |
2019-05-16 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
PT3076976T
(pt)
|
2013-12-04 |
2020-12-07 |
Kronos Bio Inc |
Métodos para tratar cancros
|
US9732031B2
(en)
|
2013-12-20 |
2017-08-15 |
Deuterx, Llc |
Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion
|
US9290505B2
(en)
|
2013-12-23 |
2016-03-22 |
Gilead Sciences, Inc. |
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
|
UY35898A
(es)
|
2013-12-23 |
2015-07-31 |
Gilead Sciences Inc |
?compuestos inhibidores de syk y composiciones que los comprenden?.
|
US9611252B2
(en)
|
2013-12-30 |
2017-04-04 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
JP6759100B2
(ja)
|
2013-12-30 |
2020-09-23 |
ライフサイ ファーマシューティカルズ,インク. |
治療用阻害化合物
|
WO2015109037A1
(en)
|
2014-01-15 |
2015-07-23 |
Deuterx, Llc |
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
|
DK3107902T3
(da)
|
2014-02-20 |
2021-05-03 |
Cornell Univ Cornell Center For Technology Enterprise & Commercialization Cctec |
Forbindelser og fremgangsmåder til at hæmme fascin
|
KR20170029580A
(ko)
|
2014-07-14 |
2017-03-15 |
길리애드 사이언시즈, 인코포레이티드 |
암을 치료하기 위한 조합물
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
HUE054347T2
(hu)
|
2014-09-17 |
2021-08-30 |
Celgene Car Llc |
MK2 inhibitorok és azok alkalmazásai
|
US10160778B2
(en)
|
2014-10-27 |
2018-12-25 |
Concert Pharmaceuticals, Inc. |
Pyrimidine phosphonic acid esters
|
MX2017005935A
(es)
|
2014-11-06 |
2018-01-11 |
Enanta Pharm Inc |
Análogos de ácido biliar como agonistas fxr/tgr5 y métodos de uso de los mismos.
|
US10208081B2
(en)
|
2014-11-26 |
2019-02-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
US11578097B2
(en)
|
2014-11-26 |
2023-02-14 |
Enanta Pharmaceuticals, Inc. |
Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
|
US20160214918A1
(en)
*
|
2015-01-22 |
2016-07-28 |
Kaohsiung Medical University |
Composition for treating metabolic syndrome and a preparation method thereof
|
CN105985396A
(zh)
*
|
2015-02-16 |
2016-10-05 |
苏州泽璟生物制药有限公司 |
氘代鹅去氧胆酸衍生物以及包含该化合物的药物组合物
|
US10947201B2
(en)
|
2015-02-17 |
2021-03-16 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
CA2978006C
(en)
|
2015-03-06 |
2024-06-25 |
Auspex Pharmaceuticals, Inc. |
Methods for the treatment of abnormal involuntary movement disorders
|
CN107427527B
(zh)
|
2015-03-31 |
2021-01-26 |
英安塔制药有限公司 |
作为fxr/tgr5激动剂的胆汁酸衍生物及其使用方法
|
EP3280420B1
(en)
*
|
2015-04-10 |
2024-03-27 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
US10683305B2
(en)
|
2015-04-27 |
2020-06-16 |
Concert Pharmaceuticals, Inc. |
Deuterated OTX-015
|
CN106279039B
(zh)
*
|
2015-06-02 |
2019-01-11 |
青岛海洋生物医药研究院股份有限公司 |
氘代脱氢苯基阿夕斯丁类化合物及其制备方法和在制备抗肿瘤的药物中的应用
|
US10981893B2
(en)
|
2015-07-01 |
2021-04-20 |
Attune Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
US9809603B1
(en)
|
2015-08-18 |
2017-11-07 |
Deuterx, Llc |
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
|
WO2017083431A2
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
WO2017087795A1
(en)
|
2015-11-19 |
2017-05-26 |
Concert Pharmaceuticals, Inc. |
Deuterated epi-743
|
EP3386536A4
(en)
|
2015-12-07 |
2019-07-31 |
Opi Vi- IP Holdco LLC |
COMPOSITION OF ANTIBODY CONSTRUCT AGONIST CONJUGATES AND METHOD FOR USE THEREOF
|
CN106892924B
(zh)
*
|
2015-12-17 |
2021-01-08 |
四川科伦博泰生物医药股份有限公司 |
短效苯并二氮*衍生物、其制备方法及其用途
|
US10442761B2
(en)
|
2016-02-16 |
2019-10-15 |
Concert Pharmaceuticals, Inc. |
Deuterated GFT-505
|
WO2017147159A1
(en)
*
|
2016-02-23 |
2017-08-31 |
Enanta Pharmaceuticals, Inc. |
Deuterated bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
JP6838074B2
(ja)
|
2016-03-08 |
2021-03-03 |
セージ セラピューティクス, インコーポレイテッド |
神経刺激性ステロイド、組成物、およびその使用
|
EP3888656A1
(en)
|
2016-03-25 |
2021-10-06 |
Intra-Cellular Therapies, Inc. |
Deuterated heterocyclic gamma-carboline compounds and their use in the treatment or prophylaxis of a central nervous system disorder
|
US11274087B2
(en)
|
2016-07-08 |
2022-03-15 |
Richter Gedeon Nyrt. |
Industrial process for the preparation of cariprazine
|
WO2018011628A1
(en)
|
2016-07-11 |
2018-01-18 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
US10544106B2
(en)
|
2016-08-15 |
2020-01-28 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
US10912769B2
(en)
*
|
2016-09-29 |
2021-02-09 |
Jiangsu Jibeier Pharmaceutical Co. Ltd. |
1-[(pyridin-3-yl-sulfonyl)-1H-pyrrol-3-yl] methanamine derivative and pharmaceutical composition and use thereof
|
CN110072518B
(zh)
|
2016-10-12 |
2021-10-26 |
细胞内治疗公司 |
无定形固体分散体
|
SG10202110181RA
(en)
|
2017-03-15 |
2021-10-28 |
Silverback Therapeutics Inc |
Benzazepine compounds, conjugates, and uses thereof
|
EP3596085A4
(en)
|
2017-03-16 |
2020-11-25 |
Celgene CAR LLC |
DEUTERATED ANALOGUES OF MK2 INHIBITORS AND THEIR USES
|
JP7200120B2
(ja)
|
2017-03-16 |
2023-01-06 |
セルジーン シーエーアール エルエルシー |
Mk2阻害剤として有用なヘテロアリール化合物
|
US11098057B2
(en)
|
2017-03-16 |
2021-08-24 |
Celgene Car Llc |
9,10,11,12-tetrahydro-8H-[1,4]diazepino[5′,6′:4,5]thieno[3,2-F]quinolin-8-one compounds and uses thereof
|
MX2019011329A
(es)
|
2017-03-24 |
2019-12-02 |
Intra Celular Therapies Inc |
Composiciones novedosas y metodos.
|
US11021471B2
(en)
|
2017-05-10 |
2021-06-01 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
WO2018223065A1
(en)
|
2017-06-01 |
2018-12-06 |
Xoc Pharmaceuticals, Inc. |
Ergoline derivatives for use in medicine
|
CN107226769A
(zh)
*
|
2017-06-19 |
2017-10-03 |
郑州泰基鸿诺医药股份有限公司 |
一种含二氟氘代甲氧(硫)基官能团的芳香类化合物的合成方法
|
CN109422731A
(zh)
*
|
2017-08-24 |
2019-03-05 |
正大天晴药业集团股份有限公司 |
氘代喹啉衍生物
|
KR102399996B1
(ko)
|
2017-08-25 |
2022-05-20 |
길리애드 사이언시즈, 인코포레이티드 |
Syk 억제제의 다형체
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
EP3703694A4
(en)
|
2017-11-03 |
2021-08-18 |
Nirsum Laboratories, Inc. |
MEDICINES ANTAGONISTS OF OPIOID RECEPTORS
|
WO2019096112A1
(zh)
*
|
2017-11-14 |
2019-05-23 |
深圳市塔吉瑞生物医药有限公司 |
一种取代的苯并咪唑化合物及包含该化合物的组合物
|
CN111491629A
(zh)
|
2017-11-22 |
2020-08-04 |
康塞特医药品公司 |
D-丝氨酸的氘化类似物及其用途
|
EP3724222A1
(en)
|
2017-12-15 |
2020-10-21 |
Silverback Therapeutics, Inc. |
Antibody construct-drug conjugate for the treatment of hepatitis
|
CN109456331B
(zh)
*
|
2017-12-22 |
2020-06-05 |
深圳市塔吉瑞生物医药有限公司 |
一种取代的吡唑并[1,5-a]嘧啶化合物及其药物组合物及用途
|
DK3740481T3
(da)
|
2018-01-19 |
2024-07-08 |
Cytokinetics Inc |
Dihydrobenzofuran- og indenanaloger som hjertesarkomerinhibitorer
|
CN109575025B
(zh)
|
2018-01-23 |
2020-09-11 |
深圳市塔吉瑞生物医药有限公司 |
取代的吡唑并[1,5-a]嘧啶类的大环化合物
|
WO2019152883A1
(en)
|
2018-02-02 |
2019-08-08 |
Padforward Llc |
Inhibitors of protein arginine deiminases
|
AU2019218893A1
(en)
|
2018-02-08 |
2020-09-03 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
EP3774798A1
(en)
|
2018-04-02 |
2021-02-17 |
Silverback Therapeutics, Inc. |
Alk5 inhibitors, conjugates, and uses thereof
|
WO2019213403A1
(en)
|
2018-05-02 |
2019-11-07 |
Kinnate Biopharma Inc. |
Inhibitors of cyclin-dependent kinases
|
SG11202011703VA
(en)
|
2018-05-25 |
2020-12-30 |
Silverback Therapeutics Inc |
Amino-pyrazinecarboxamide compounds, conjugates, and uses thereof
|
WO2020005887A1
(en)
|
2018-06-26 |
2020-01-02 |
Cytokinetics, Inc. |
Cardiac sarcomere inhibitors
|
JP2021529746A
(ja)
|
2018-06-26 |
2021-11-04 |
サイトキネティックス, インコーポレイテッド |
心臓サルコメア阻害剤
|
AU2019291935A1
(en)
|
2018-06-29 |
2021-02-04 |
Kinnate Biopharma Inc. |
Inhibitors of cyclin-dependent kinases
|
CN109020875B
(zh)
*
|
2018-08-27 |
2020-05-22 |
北京市药品检验所 |
二氢吡啶类化合物脱氢芳构化方法及在药品检测中的用途
|
AU2019328528A1
(en)
|
2018-08-31 |
2021-03-18 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
MX2021002321A
(es)
|
2018-08-31 |
2021-04-28 |
Intra Cellular Therapies Inc |
Nuevos metodos.
|
CN112867539B
(zh)
|
2018-08-31 |
2024-08-06 |
赛特凯恩蒂克公司 |
心脏肌小节抑制剂
|
AU2019334994A1
(en)
*
|
2018-09-05 |
2021-04-08 |
Lupin Inc. |
Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof
|
CN113166113A
(zh)
|
2018-09-12 |
2021-07-23 |
希沃尔拜克治疗公司 |
取代的苯并氮杂䓬化合物、缀合物及其用途
|
CA3111784A1
(en)
|
2018-09-12 |
2020-03-19 |
Silverback Therapeutics, Inc. |
Methods and compositions for the treatment of disease with immune stimulatory conjugates
|
WO2020056194A1
(en)
|
2018-09-12 |
2020-03-19 |
Silverback Therapeutics, Inc. |
Benzazepine compounds, conjugates, and uses thereof
|
AU2019345150A1
(en)
|
2018-09-20 |
2021-05-13 |
Blacksmith Medicines, Inc. |
Antibacterial compounds
|
CA3116315A1
(en)
|
2018-10-16 |
2020-04-23 |
Glo Pharma, Inc. |
Nicotinic acetylcholine receptor peptide antagonist conotoxin compositions and related methods
|
MX2021005348A
(es)
|
2018-11-06 |
2021-08-11 |
Edgewise Therapeutics Inc |
Compuestos de piridazinonas y usos de los mismos.
|
CA3118904A1
(en)
|
2018-11-06 |
2020-05-14 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
MX2021005350A
(es)
|
2018-11-06 |
2021-08-11 |
Edgewise Therapeutics Inc |
Compuestos de piridazinona y usos de los mismos.
|
US11535600B2
(en)
|
2018-12-03 |
2022-12-27 |
H. Lundbeck A/S |
Prodrugs of 4-((1R,3S)-6-chloro-3-phenyl-2,3-dihydro-1H-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1R,3S)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1H-inden-1-yl)-2,2-dimethyl-1-(methyl-d3)piperazine
|
KR102643707B1
(ko)
|
2019-01-22 |
2024-03-04 |
에오비안 파마슈티컬스, 인크. |
Mtorc 조절제 및 이의 용도
|
CA3130693A1
(en)
|
2019-02-19 |
2020-08-27 |
Ultima Genomics, Inc. |
Linkers and methods for optical detection and sequencing
|
JP2022521413A
(ja)
|
2019-02-22 |
2022-04-07 |
クロノス バイオ インコーポレイテッド |
Syk阻害剤としての縮合ピラジンの固体形態
|
CA3131104A1
(en)
|
2019-03-06 |
2020-09-10 |
Silverback Therapeutics, Inc. |
Cyclic amino-pyrazinecarboxamide compounds and uses thereof
|
WO2020206367A1
(en)
|
2019-04-03 |
2020-10-08 |
Concert Pharmaceuticals, Inc. |
Processes for the preparation of deuterated d-serine
|
US11547707B2
(en)
|
2019-04-10 |
2023-01-10 |
Richter Gedeon Nyrt. |
Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
|
CN114007625A
(zh)
|
2019-04-18 |
2022-02-01 |
阿祖拉眼科有限公司 |
用于治疗眼病的化合物和方法
|
JP2022530322A
(ja)
|
2019-04-18 |
2022-06-29 |
アズーラ オフサルミックス エルティーディー. |
眼障害を処置するための化合物および方法
|
TW202106684A
(zh)
|
2019-05-03 |
2021-02-16 |
美商奇奈特生物製藥公司 |
Raf激酶抑制劑
|
WO2020226628A1
(en)
|
2019-05-07 |
2020-11-12 |
Nirsum Laboratories, Inc. |
Opioid receptor antagonist prodrugs for treating opioid dependence
|
WO2020247540A1
(en)
|
2019-06-03 |
2020-12-10 |
Biointervene, Inc. |
Adenosine analogs for the treatment of disease
|
WO2020247546A1
(en)
|
2019-06-03 |
2020-12-10 |
Biointervene, Inc. |
Adenosine analogs for the treatment of disease
|
KR20220029744A
(ko)
|
2019-07-07 |
2022-03-08 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규 방법
|
WO2021007172A1
(en)
|
2019-07-08 |
2021-01-14 |
Belite Bio, Llc |
Formulations of rbp4 inhibitors and methods of use
|
WO2021011834A1
(en)
|
2019-07-16 |
2021-01-21 |
Silverback Therapeutics, Inc. |
Alk5 inhibitors, conjugates, and uses thereof
|
AU2020348685A1
(en)
|
2019-09-16 |
2022-04-14 |
Dice Alpha, Inc. |
IL-17A modulators and uses thereof
|
WO2021067644A1
(en)
|
2019-10-01 |
2021-04-08 |
Silverback Therapeutics, Inc. |
Combination therapy with immune stimulatory conjugates
|
JP2022552655A
(ja)
|
2019-10-07 |
2022-12-19 |
キャリーオペ,インク. |
Gpr119アゴニスト
|
WO2021072203A1
(en)
|
2019-10-09 |
2021-04-15 |
Silverback Therapeutics, Inc. |
Tgfbetar1 inhibitor-asgr antibody conjugates and uses thereof
|
WO2021072330A1
(en)
|
2019-10-09 |
2021-04-15 |
Silverback Therapeutics, Inc. |
Galnac-tgfbr1 inhibitor conjugates for the treatment of liver diseases
|
IL292424A
(en)
|
2019-10-24 |
2022-06-01 |
Kinnate Biopharma Inc |
Inhibitors of raf kinases
|
WO2021102332A1
(en)
|
2019-11-22 |
2021-05-27 |
Silverback Therapeutics, Inc. |
Tgfbetar2 inhibitor-lrrc15 antibody conjugates and uses thereof
|
EP4069699A1
(en)
|
2019-12-05 |
2022-10-12 |
Verge Analytics, Inc. |
Fused tricyclic heterocyclic compounds as inhibitors of pikfyve kinase useful for the treatment of neurological diseases
|
TW202140483A
(zh)
|
2020-01-13 |
2021-11-01 |
美商邊際分析公司 |
經取代吡唑并嘧啶及其用途
|
JP2023512786A
(ja)
|
2020-02-07 |
2023-03-29 |
サイトキネティックス, インコーポレイテッド |
Namptモジュレーター
|
US11807851B1
(en)
|
2020-02-18 |
2023-11-07 |
Ultima Genomics, Inc. |
Modified polynucleotides and uses thereof
|
JP2023514727A
(ja)
|
2020-02-21 |
2023-04-07 |
シルバーバック セラピューティックス インコーポレイテッド |
ネクチン-4抗体コンジュゲートおよびその使用
|
WO2021183439A1
(en)
|
2020-03-09 |
2021-09-16 |
Verge Analytics, Inc. |
Substituted furo[3,2-d]pyrimidines and uses thereof
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
EP4146344A1
(en)
|
2020-05-04 |
2023-03-15 |
Volastra Therapeutics, Inc. |
Imino sulfanone inhibitors of enpp1
|
CA3181351A1
(en)
|
2020-05-06 |
2021-11-11 |
Antonio Romero |
Nampt modulators
|
EP4149620A1
(en)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds for the treatment of neuromuscular diseases
|
WO2021231546A1
(en)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
EP4149466A1
(en)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
WO2021231572A1
(en)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds for the treatment of neuromuscular diseases
|
EP4149467A1
(en)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
CN116348451A
(zh)
|
2020-05-14 |
2023-06-27 |
维艾尔生物科技有限公司 |
Enpp1调节剂及其用途
|
UY39222A
(es)
|
2020-05-19 |
2021-11-30 |
Kallyope Inc |
Activadores de la ampk
|
US11345681B1
(en)
|
2020-06-05 |
2022-05-31 |
Kinnate Biopharma Inc. |
Inhibitors of fibroblast growth factor receptor kinases
|
US12091412B2
(en)
|
2020-06-16 |
2024-09-17 |
Volastra Therapeutics, Inc. |
Heterocyclic inhibitors of ENPP1
|
EP4172162A4
(en)
|
2020-06-26 |
2024-08-07 |
Kallyope Inc |
AMPK ACTIVATORS
|
US11767317B1
(en)
|
2020-06-30 |
2023-09-26 |
Poxel Sa |
Methods of synthesizing enantiopure deuterium-enriched pioglitazone
|
US11319313B2
(en)
|
2020-06-30 |
2022-05-03 |
Poxel Sa |
Crystalline forms of deuterium-enriched pioglitazone
|
EP4175673A1
(en)
|
2020-07-01 |
2023-05-10 |
ARS Pharmaceuticals Inc. |
Anti-asgr1 antibody conjugates and uses thereof
|
WO2022020522A2
(en)
|
2020-07-21 |
2022-01-27 |
Aeovian Pharmaceuticals, Inc. |
Mtorc1 modulators and uses thereof
|
CA3190021A1
(en)
|
2020-08-17 |
2022-02-24 |
Charles J. Cohen |
A3 adenosine receptor agonists for use in medicine
|
WO2022045837A1
(ko)
*
|
2020-08-27 |
2022-03-03 |
주식회사 엘지화학 |
중수소화 방향족 화합물의 제조 방법 및 중수소화 반응 조성물
|
CN111995574B
(zh)
*
|
2020-08-28 |
2024-05-17 |
西安明喆药品生产有限公司 |
氘代羟氯喹衍生物以及包含该化合物的药物组合物
|
WO2022060996A1
(en)
|
2020-09-18 |
2022-03-24 |
Kinnate Biopharma Inc. |
Inhibitors of raf kinases
|
US11377431B2
(en)
|
2020-10-12 |
2022-07-05 |
Kinnate Biopharma Inc. |
Inhibitors of RAF kinases
|
AR124008A1
(es)
|
2020-11-06 |
2023-02-01 |
Cytokinetics Inc |
1,4-diazepanonas bicíclicas y sus usos terapéuticos
|
MX2023005971A
(es)
|
2020-11-20 |
2023-06-07 |
2692372 Ontario Inc |
Metodos y composicion para las modificaciones de kras.
|
US20240018153A1
(en)
|
2020-11-20 |
2024-01-18 |
2692372 Ontario, Inc. |
Benzenesulfonamide derivatives and uses thereof
|
WO2022140290A1
(en)
|
2020-12-21 |
2022-06-30 |
Cytokinetics, Inc. |
Pyrazole derivatives useful as nampt modulators
|
WO2022169882A1
(en)
|
2021-02-03 |
2022-08-11 |
Verge Analytics, Inc. |
Methods and treatment of viral infection caused by sars-cov-2
|
CN117222641A
(zh)
|
2021-02-24 |
2023-12-12 |
英矽智能科技知识产权有限公司 |
用于治疗疾病的类似物
|
WO2022187501A1
(en)
|
2021-03-04 |
2022-09-09 |
Cytokinetics, Inc. |
Cardiac sarcomere inhibitors
|
US11459351B1
(en)
|
2021-04-05 |
2022-10-04 |
Azura Ophthalmics Ltd. |
Compounds and methods for the treatment of ocular disorders
|
WO2022217118A1
(en)
|
2021-04-09 |
2022-10-13 |
Quanta Therapeutics, Inc. |
Pyrimidine based ras modulators and uses thereof
|
CA3223210A1
(en)
*
|
2021-04-23 |
2022-12-27 |
Gilgamesh Pharmaceuticals, Inc. |
Novel ergolines and methods of treating mood disorders
|
KR20240000534A
(ko)
|
2021-04-23 |
2024-01-02 |
킨네이트 바이오파마 인크. |
Raf 억제제를 이용하는 암의 치료
|
AR126013A1
(es)
|
2021-06-01 |
2023-08-30 |
Verge Analytics Inc |
Compuestos heterocíclicos bicíclicos fusionados y usos de los mismos
|
TW202313626A
(zh)
|
2021-06-01 |
2023-04-01 |
美商邊際分析公司 |
稠合雙環雜環化合物及其用途
|
WO2022256297A1
(en)
|
2021-06-01 |
2022-12-08 |
Verge Analytics, Inc. |
2-(3-phenyl-1h-pyrazol-1-yl)-4-morpholino-5h-pyrrolo[3,2-d]pyrimidine derivatives and similar compounds as pikfyve kinase inhibitors for the treatment of e.g. amyotrophic lateral sclerosis (als)
|
WO2022256298A1
(en)
|
2021-06-01 |
2022-12-08 |
Verge Analytics, Inc. |
7-(3-phenyl-1 h-pyrazol-1-yl)-5-morpholino-imidazo[1,2-a]pyrimidine derivatives and similar compounds as pikfyve kinase inhibitors for the treatment of e.g. amyotrophic lateral sclerosis (als)
|
TW202313051A
(zh)
|
2021-06-08 |
2023-04-01 |
美商邊際分析公司 |
使用經取代呋喃并嘧啶之病毒感染治療及方法
|
WO2022263829A1
(en)
|
2021-06-16 |
2022-12-22 |
Z Factor Limited |
COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY
|
JP2024523552A
(ja)
|
2021-06-24 |
2024-06-28 |
インシリコ メディシン アイピー リミテッド |
疾患の処置のためのベータ-ラクタム誘導体
|
JP2024525672A
(ja)
|
2021-07-09 |
2024-07-12 |
ダイス・アルファ・インコーポレイテッド |
フェニルacetアミドに基づくil-17a調節因子およびその使用
|
JP2024525692A
(ja)
|
2021-07-12 |
2024-07-12 |
サイトキネティックス, インコーポレイテッド |
Cd38調節因子及びその使用方法
|
KR20240109977A
(ko)
|
2021-08-26 |
2024-07-12 |
볼라스트라 쎄라퓨틱스, 인코포레이티드 |
Kif18a의 스피로 인돌린 억제제
|
WO2023070114A2
(en)
|
2021-10-22 |
2023-04-27 |
Terremoto Biosciences, Inc. |
Reversible lysine covalent modifiers of egfr and uses thereof
|
WO2023076866A1
(en)
|
2021-10-25 |
2023-05-04 |
Volastra Therapeutics, Inc. |
Tricyclic sulfoximine inhibitors of enpp1
|
WO2023081312A1
(en)
|
2021-11-04 |
2023-05-11 |
Vir Biotechnology, Inc. |
Small molecule inducers of autophagy
|
KR20240117556A
(ko)
|
2021-11-12 |
2024-08-01 |
인실리코 메디신 아이피 리미티드 |
유비퀴틴 특이적 프로테아제 1(usp1)의 소분자 억제제 및 이의 용도
|
EP4433455A1
(en)
|
2021-11-15 |
2024-09-25 |
VIR Biotechnology, Inc. |
Enpp1 modulators and uses thereof
|
EP4433473A1
(en)
|
2021-11-17 |
2024-09-25 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
WO2023114733A1
(en)
|
2021-12-13 |
2023-06-22 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
WO2023114428A1
(en)
|
2021-12-16 |
2023-06-22 |
Vir Biotechnology, Inc. |
Heterocycle derivatives for the treatment of disease
|
TW202333709A
(zh)
|
2021-12-16 |
2023-09-01 |
美商奇奈特生物製藥公司 |
Met激酶抑制劑
|
TW202342055A
(zh)
|
2022-02-03 |
2023-11-01 |
美商奇奈特生物製藥公司 |
Raf激酶抑制劑
|
WO2023154766A1
(en)
|
2022-02-09 |
2023-08-17 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
AR128586A1
(es)
|
2022-02-25 |
2024-05-22 |
Dice Alpha Inc |
Moduladores de il-17a a base de di-ciclopropilo y sus usos
|
AR128669A1
(es)
|
2022-03-01 |
2024-06-05 |
Insilico Medicine Ip Ltd |
INHIBIDORES DE DIACILGLICEROL CINASA (DGK) a Y USOS DE LOS MISMOS
|
WO2023168291A1
(en)
|
2022-03-02 |
2023-09-07 |
Terremoto Biosciences, Inc. |
Covalent modifiers of akt1 and uses thereof
|
TW202342018A
(zh)
|
2022-03-04 |
2023-11-01 |
美商奇奈特生物製藥公司 |
Mek激酶抑制劑
|
WO2023178144A2
(en)
|
2022-03-16 |
2023-09-21 |
Empirico Inc. |
Galnac compositions for improving sirna bioavailability
|
WO2023198873A1
(en)
*
|
2022-04-14 |
2023-10-19 |
Immunic Ag |
Deuterated rorgamma/rorgammat inverse agonists
|
WO2023212240A1
(en)
|
2022-04-28 |
2023-11-02 |
Volastra Therapeutics, Inc. |
Compounds for inhibiting kif18a
|
WO2023215367A1
(en)
|
2022-05-04 |
2023-11-09 |
Cytokinetics, Inc. |
Bicyclic piperazinones and therapeutic uses thereof
|
WO2023220741A1
(en)
|
2022-05-13 |
2023-11-16 |
Dice Molecules Sv, Inc. |
Alpha 4 beta 7 integrin modulators and uses thereof
|
WO2023225001A1
(en)
|
2022-05-16 |
2023-11-23 |
Vir Biotechnology, Inc. |
Naphthyridine based enpp1 modulators and uses thereof
|
US11939335B2
(en)
|
2022-05-17 |
2024-03-26 |
858 Therapeutics, Inc. |
Substituted imidazo[1,2-a]quinazolines and imidazo [1,2-a]pyrido[4,3-e]pyrimidines as inhibitors of PARG
|
WO2023225664A1
(en)
|
2022-05-19 |
2023-11-23 |
Dice Alpha, Inc. |
Lactam substituted imidazopyridazine il-17a modulators and uses thereof
|
WO2023230190A1
(en)
|
2022-05-25 |
2023-11-30 |
Quanta Therapeutics, Inc. |
Pyrimidine based modulators and uses thereof
|
WO2023235880A1
(en)
|
2022-06-02 |
2023-12-07 |
Aeovian Pharmaceuticals, Inc. |
Cd38 modulators and uses thereof
|
WO2023240253A2
(en)
|
2022-06-10 |
2023-12-14 |
Forward Therapeutics, Inc. |
Modulators of tnf-alpha activity
|
WO2023245137A1
(en)
|
2022-06-16 |
2023-12-21 |
Cytokinetics, Incorporated |
Slow skeletal troponin activators
|
US20240092761A1
(en)
|
2022-07-18 |
2024-03-21 |
Iambic Therapeutics, Inc. |
Quinazoline compounds and methods of use
|
TW202412784A
(zh)
|
2022-07-18 |
2024-04-01 |
美商依安彼克醫療有限公司 |
氮-喹唑啉化合物及使用方法
|
WO2024020517A1
(en)
|
2022-07-22 |
2024-01-25 |
858 Therapeutics, Inc. |
3-(6-pyridin-3-yl)-2-[4-(4-methyl-4h-1,2,4-triazol-3-yl)piperidin-1-yl]benzonitrile derivatives and similar compounds as qpctl and qpct inhibitors for the treatment of cancer
|
WO2024030825A1
(en)
|
2022-08-01 |
2024-02-08 |
Neupharma, Inc |
Crystalline salts of crystalline salts of (3s,5r,8r,9s,10s,13r,14s,17r)-14-hydroxy-10,13-dimethyl-17-(2- oxo-2h-pyran-5-yl)hexadecahydro-1h-cyclopenta[a]phenanthren-3-yl piperazine-1-carboxylate
|
WO2024040190A1
(en)
|
2022-08-18 |
2024-02-22 |
Cytokinetics, Incorporated |
Indane and coumaran derivatives as fast skeletal muscle myosin inhibitors
|
WO2024064701A2
(en)
|
2022-09-20 |
2024-03-28 |
Biointervene, Inc. |
Adenosine analogs for the treatment of disease
|
WO2024073426A1
(en)
|
2022-09-26 |
2024-04-04 |
Edgewise Therapeutics, Inc. |
1,4-dihydroquinazolinone compounds and uses thereof
|
WO2024073371A1
(en)
|
2022-09-26 |
2024-04-04 |
Alterome Therapeutics, Inc. |
Akt1 modulators
|
WO2024105159A1
(en)
|
2022-11-16 |
2024-05-23 |
University Of Zurich |
Ligands of the m6a-rna readers
|
US20240279215A1
(en)
|
2022-12-22 |
2024-08-22 |
Cytokinetics, Incorporated |
Nampt modulators
|
WO2024163365A1
(en)
|
2023-01-30 |
2024-08-08 |
Dice Alpha, Inc. |
Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof
|
WO2024168016A1
(en)
|
2023-02-10 |
2024-08-15 |
Verge Analytics, Inc. |
Substituted pyrazolo-pyrimidines and uses thereof
|
WO2024173173A1
(en)
|
2023-02-13 |
2024-08-22 |
Dice Alpha, Inc. |
Imidazotriazine il-17a modulators and uses thereof
|
WO2024178255A1
(en)
|
2023-02-23 |
2024-08-29 |
Volastra Therapeutics, Inc. |
Solid formulations and polymorphic forms of indoline inhibitors of kif18a
|
WO2024178390A1
(en)
|
2023-02-24 |
2024-08-29 |
Terremoto Biosciences, Inc. |
Covalent modifiers of akt1 and uses thereof
|
WO2024182404A1
(en)
|
2023-02-28 |
2024-09-06 |
Vividion Therapeutics, Inc |
1-(([1, 1',-biphenyl]-2-yl)sulfonyl)-4-fluoro-n-(3-(methylsulfonyl)allyl)piperidine-4-carboxamide derivatives as ras-pi3k modulators for the treatment of e.g. cancer
|
WO2024182447A1
(en)
|
2023-02-28 |
2024-09-06 |
Vividion Therapeutics, Inc. |
Compounds and methods for modulating ras-pi3k
|
WO2024182693A1
(en)
|
2023-03-02 |
2024-09-06 |
Vividion Therapeutics, Inc. |
2-azaspiro[3.3]heptane derivatives as stat3 inhibitors for the treatment of cancer
|